InsiderTrades

Form 4 for AHCO AdaptHealth Corp.

Accepted 2023-05-10 00:00:00 ET · period of report 2023-05-08 · accession 0001104659-23-058612 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-10 2023-05-08 AHCO GRIGGS STEPHEN P CEO, Dir M - OptEx $4.38 +559.1K 743.5K +303% +$2.45M
D 2023-05-10 2023-05-08 AHCO GRIGGS STEPHEN P CEO, Dir F - Tax $11.86 -345.2K 398.3K -46% -$4.09M
D 2023-05-10 2023-05-08 AHCO GRIGGS STEPHEN P CEO, Dir M - OptEx $0.00 -559.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 per share ("Common Stock") 2023-05-08 M A 559,071 $4.38 743,534 D — —
2 Common Common Stock 2023-05-08 F D 345,219 $11.86 398,315 D — —
3 Derivative Employee Stock Option (right to buy) 2023-05-08 M D 559,071 $0.00 0 D $4.38 · — to 2026-08-01 559,071 Common Stock (F3) On December 1, 2020, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc., AH Apollo Merger Sub II Inc., Peloton Equity, LLC and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger (the "AeroCare Merger") occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and options to acquire Common Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Common Stock and Series C Preferred Stock and options to acquire Common Stock, respectively, pursuant to the Merger Agreement. (F4) Options were fully vested as of the effective time if the AeroCare Merger.